Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Proto Labs (PRLB) over the last 15 years, with Q3 2025 value amounting to $2000.0.

  • Proto Labs' Gains from Investment Securities changed N/A to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 6635.42%. This contributed to the annual value of $2.0 million for FY2024, which is 3892.76% up from last year.
  • Per Proto Labs' latest filing, its Gains from Investment Securities stood at $2000.0 for Q3 2025.
  • In the past 5 years, Proto Labs' Gains from Investment Securities ranged from a high of $1.9 million in Q2 2025 and a low of -$4.7 million during Q4 2021
  • In the last 5 years, Proto Labs' Gains from Investment Securities had a median value of $249894.0 in 2021 and averaged $196293.1.
  • In the last 5 years, Proto Labs' Gains from Investment Securities crashed by 33315.3% in 2021 and then surged by 36381.85% in 2023.
  • Quarter analysis of 5 years shows Proto Labs' Gains from Investment Securities stood at -$4.7 million in 2021, then skyrocketed by 101.41% to $67000.0 in 2022, then tumbled by 83.58% to $11000.0 in 2023, then surged by 581.82% to $75000.0 in 2024, then crashed by 97.33% to $2000.0 in 2025.
  • Its Gains from Investment Securities stands at $2000.0 for Q3 2025, versus $1.9 million for Q2 2025 and $1.2 million for Q1 2025.